​

Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?

OverviewForecastFinancialsChart

Bicara Therapeutics Ownership Summary

Bicara Therapeutics is owned by 93.81% institutional investors, 12.23% insiders. Ra capital management is the largest institutional shareholder, holding 12.75% of BCAX shares.

BCAX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicara Therapeutics93.81%12.23%-6.05%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.96M12.75%$64.62M
Siren5.22M9.57%$48.47M
Vestal point capital, lp5.00M9.17%$46.45M
Deep track capital, lp2.43M4.45%$22.54M
Omega fund management2.20M4.04%$20.48M
Blackrock funding, inc. /de2.11M3.87%$19.61M
Blackstone1.22M2.24%$11.37M
Fil1.01M1.86%$9.42M
Foresite capital management vi949.26K1.74%$8.82M
Aisling capital management lp568.92K1.04%$5.29M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Omega fund management2.20M13.26%$20.48M
Foresite capital management vi949.26K4.96%$8.82M
Siren5.22M2.51%$48.47M
Vestal point capital, lp5.00M2.45%$46.45M
Superstring capital management lp189.70K2.09%$1.76M
Aisling capital management lp568.92K1.47%$5.29M
Sectoral asset management201.40K1.24%$1.87M
Ra capital management6.96M1.09%$64.62M
Caxton10.94K1.03%$101.64K
Dafna capital management317.00K0.81%$2.94M

Top Buyers

HolderShares% AssetsChange
Vestal point capital, lp5.00M2.45%2.23M
Siren5.22M2.51%1.95M
Blackrock funding, inc. /de2.11M0.00%769.39K
Deep track capital, lp2.43M0.72%426.66K
Artisan partners limited partnership402.76K0.01%402.76K

Top Sellers

HolderShares% AssetsChange
Braidwell lp---2.16M
Deerfield management company, l.p. (series c)---1.80M
Wellington management group llp---1.39M
Janus henderson group---1.34M
Adage capital partners gp---1.18M

New Positions

HolderShares% AssetsChangeValue
Artisan partners limited partnership402.76K0.01%402.76K$3.74M
Logos global management lp400.00K0.41%400.00K$3.72M
Nan fung trinity (hk)342.88K0.38%342.88K$3.19M
Readystate asset management lp270.20K0.08%270.20K$2.51M
Point72 asset management216.84K0.00%216.84K$2.01M

Sold Out

HolderChange
Farther finance advisors-16.00
Mrp capital investments-20.00
Rothschild investment-20.00
Signaturefd-80.00
Simplex trading-154.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202510519.32%51,165,42915.59%931.42%7946.30%16-
Mar 31, 20259213.58%48,567,5534.69%891.23%54-10.00%18157.14%
Dec 31, 20248322.06%46,705,50728.51%851.92%62-8.82%7-
Sep 30, 202468-36,343,123-66-68---

Recent Insider Transactions

DateNameRoleActivityValue
Jun 16, 2025Meisner Lara Chief Legal OfficerSell$165.10K
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$615.70K
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$405.51K
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$30.25M
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$2.74M

Insider Transactions Trends

DateBuySell
2025 Q2-1
2025 Q1-2
2024 Q33-

BCAX Ownership FAQ

Who Owns Bicara Therapeutics?

Bicara Therapeutics shareholders are primarily institutional investors at 93.81%, followed by 12.23% insiders and -6.04% retail investors. The average institutional ownership in Bicara Therapeutics's industry, Biotech Stocks , is 304.14%, which Bicara Therapeutics falls below.

Who owns the most shares of Bicara Therapeutics?

Bicara Therapeutics’s largest shareholders are Ra capital management (6.96M shares, 12.75%), Siren (5.22M shares, 9.57%), and Vestal point capital, lp (5M shares, 9.17%). Together, they hold 31.49% of Bicara Therapeutics’s total shares outstanding.

Does Blackrock own Bicara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicara Therapeutics.

Who is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested?

Omega fund management is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested, with 13.26% of its assets in 2.2M Bicara Therapeutics shares, valued at 20.48M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools